These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 27019141)

  • 1. Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: Methodology and recommendations.
    Connor TH; Zock MD; Snow AH
    J Occup Environ Hyg; 2016 Sep; 13(9):658-67. PubMed ID: 27019141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches to wipe sampling methods for antineoplastic and other hazardous drugs in healthcare settings.
    Connor TH; Smith JP
    Pharm Technol Hosp Pharm; 2016 Sep; 1(3):107-114. PubMed ID: 28459100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals.
    Hedmer M; Wohlfart G
    J Environ Monit; 2012 Jul; 14(7):1968-75. PubMed ID: 22692549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of surface wipe sampling compared to biologic monitoring for occupational exposure to antineoplastic drugs.
    Kibby T
    J Occup Environ Hyg; 2017 Mar; 14(3):159-174. PubMed ID: 27676216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the efficacy of additional measures introduced for the protection of healthcare personnel handling antineoplastic drugs.
    Odraska P; Dolezalova L; Kuta J; Oravec M; Piler P; Blaha L
    Ann Occup Hyg; 2013 Mar; 57(2):240-50. PubMed ID: 22926784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies - the MEWIP project.
    Kiffmeyer TK; Tuerk J; Hahn M; Stuetzer H; Hadtstein C; Heinemann A; Eickmann U
    Ann Occup Hyg; 2013 May; 57(4):444-55. PubMed ID: 23125441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to Develop and Maintain a Hazardous Drug List.
    Dillon LR
    Int J Pharm Compd; 2019; 23(3):182-186. PubMed ID: 31085785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device.
    Siderov J; Kirsa S; McLauchlan R
    J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial and Temporal Variability in Antineoplastic Drug Surface Contamination in Cancer Care Centers in Alberta and Minnesota.
    Jeronimo M; Arnold S; Astrakianakis G; Lyden G; Stewart Q; Petersen A; Chambers C; Malard Johnson D; Zimdars E; Kaup H; Davies HW
    Ann Work Expo Health; 2021 Aug; 65(7):760-774. PubMed ID: 33889938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals.
    Viegas S; Pádua M; Veiga AC; Carolino E; Gomes M
    Environ Monit Assess; 2014 Nov; 186(11):7807-18. PubMed ID: 25096642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between occupational exposure and control measures for antineoplastic drugs in a pharmacy of a hospital.
    Yoshida J; Koda S; Nishida S; Nakano H; Tei G; Kumagai S
    Ann Occup Hyg; 2013 Mar; 57(2):251-60. PubMed ID: 23002276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to assessing occupational exposure to antineoplastic drugs in hospital environments.
    Dugheri S; Bonari A; Pompilio I; Boccalon P; Mucci N; Arcangeli G
    Arh Hig Rada Toksikol; 2018 Sep; 69(3):226-237. PubMed ID: 30285941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of novel field measurement and field evaluation protocols for assessing health care workers' exposure risk to antineoplastic drugs.
    Astrakianakis G; Jeronimo M; Griffiths A; Colombo M; Kramer D; Demers PA; Hon CY
    J Occup Environ Hyg; 2020 Sep; 17(9):373-382. PubMed ID: 32615872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environment.
    Pretty JR; Connor TH; Spasojevic I; Kurtz KS; McLaurin JL; B'Hymer C; Debord DG
    J Oncol Pharm Pract; 2012 Mar; 18(1):23-36. PubMed ID: 21183556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns and characteristics associated with surface contamination of hazardous drugs in hospital pharmacies.
    Salch SA; Zamboni WC; Zamboni BA; Eckel SF
    Am J Health Syst Pharm; 2019 Apr; 76(9):591-598. PubMed ID: 31361828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system.
    Hon CY; Teschke K; Demers PA; Venners S
    Ann Occup Hyg; 2014 Jul; 58(6):761-70. PubMed ID: 24644303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wipe Sampling Method and Evaluation of Environmental Variables for Assessing Surface Contamination of 10 Antineoplastic Drugs by Liquid Chromatography/Tandem Mass Spectrometry.
    Colombo M; Jeronimo M; Astrakianakis G; Apte C; Hon CY
    Ann Work Expo Health; 2017 Oct; 61(8):1003-1014. PubMed ID: 29028255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of arsenic surface contamination in a museum anthropology department.
    Gribovich A; Lacey S; Franke J; Hinkamp D
    J Occup Environ Med; 2013 Feb; 55(2):164-7. PubMed ID: 23291998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring Surface Contamination by Antineoplastic Drugs in Italian Hospitals: Performance-Based Hygienic Guidance Values (HGVs) Project.
    Sottani C; Grignani E; Oddone E; Dezza B; Negri S; Villani S; Cottica D
    Ann Work Expo Health; 2017 Oct; 61(8):994-1002. PubMed ID: 29028251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons learned from surface wipe sampling for lead in three workplaces.
    Beaucham C; Ceballos D; King B
    J Occup Environ Hyg; 2017 Aug; 14(8):611-619. PubMed ID: 28574761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.